Aurobindo Pharma informs about earnings call transcript

Aurobindo Pharma Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 524804 | NSE: AUROPHARMA

18 Nov 2024 Evaluate

With refer to letter dated November 4, 2024 intimated about the schedule of Investors/ Analysts call on November 11, 2024. Aurobindo Pharma has attached the Transcript of the said analyst / investor call on the Unaudited Financial Results of the Company for the second quarter and half year ended September 30, 2024 and the same is being uploaded on the website of the Company and is available in the following web link. https://www.aurobindo.com/investors/disclosures-under-regulation-46/investor-meet/conference-calltranscripts/

The above information is a part of company’s filings submitted to BSE.

Peers

Company Name	CMP
Sun Pharma. Inds.	1866.00
Dr. Reddys Labs.	1172.05
Cipla	1372.25
Lupin	2092.00
Zydus Lifesciences	1137.35
View more..

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.